Logo

Paired Ends: John Boyce, Josh Forsythe

Apr 15, 2014
Premium

John Boyce will head up Bio-Rad's Cambridge-based Digital Biology Center, formed as part of Bio-Rad's acquisition of GnuBio last week. Boyce was previously co-founder, president, and CEO of GnuBio. Before that, he was head of business development and scientific collaborations at Helicos. He was also senior director of commercial development at Parallele Biosciences (now Affymetrix) and senior director of sales and marketing at Sequenom.

Knome has appointed Josh Forsythe to vice president of sales and marketing. He joins Knome from Golden Helix, where he was most recently VP of business development.

Filed under

Clinical Sequencing
Sequencing
Next-Generation Sequencing
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.